Ikarian Capital »

United Therapeutics Corporation shares owned by Ikarian Capital

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $89M 212k 419.21
2022-06-30 $9.4M 40k 235.65
2022-03-31 $18M 100k 179.42
2021-03-31 $18M 105k 167.26
2020-12-31 $11M 69k 151.80

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Assetmark
Invesco
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation